Company: OPGN
Filing Date: 2025-10-31
Form Type: 10-Q
Source: 0001829126-25-008771
Chunk: 78

Company: OPGEN INC
Filing Date: 2025-10-31
Form: 10-Q
Item: Part I, Item 8
Chunk 78
---
2025 compared
        to the same period in 2024. The decreases are primarily attributable to the Company scaling down its legacy operations and repositioning
        its business. 

25

Other
income (expense)

    Three Months Ended
        June 30,

    2025

    2024

    Interest and other income
     
    $
    108,843

    $
    150,658

    Interest expense

    (1,623
    )

    (1,079
    )
  
    Change in fair value of EIB loan guaranty

    -

    (178,802
    )
  
    Foreign currency transaction
        (losses) gains

    (3
    )

    184

    Total other income
        (expense)
     
    $
    107,217

    $
    (29,039
    )

Our
total other income for the three months ended June 30, 2025 consisted primarily of sublease income. Total other expense for the three
months ended June 30, 2024 consisted primarily of the change in fair value of our EIB loan guaranty, partially offset by interest
and other income consisting primarily of sublease income.

26

Results
of operations for the six months ended June 30, 2025 and 2024

Revenues

    Six Months Ended
        June 30,

    2025

    2024

    Product sales
     
    $
    -

    $
    169,373

    Laboratory services

    -

    26,776

    Listing sponsorship services

    4,000,000

    -

    Total revenue
     
    $
    4,000,000

    $
    196,149

We recognized revenue in the six months ended
June 30, 2025 solely related to our single contract to provide listing sponsorship and consulting services, as CapForce completed the
second performance obligation within the Engagement Agreement, earning proceeds of $4.0 million in the Client’s equity. We did not
generate any product sales or laboratory services revenue in the six months ended June 30, 2025, due to the winding down of our legacy
precision medicine business and repositioning ourselves in the financial services and technology industry.

Operating
expenses

    Six Months Ended
        June 30,

    2025

    2024

    Cost of products sold